Skip to main content
. 2023 Jan 5;16:77–86. doi: 10.2147/IDR.S391295

Table 2.

Antibiotic Sensitivity Pattern of E. coli and MSSA Isolates

Antibiotics E.coli MSSA
Sensitivity n (%) Sensitivity n (%)
Cephalosporin
Cefoxitin NT 130/130(100)
Cefazolin NT (85.7)
Cefuroxime 5/88(5.7) 30/47(63.8)
Cefoperazone + Sulbactam 18/30(60) NT
Ceftriaxone 8/100(8) 26/45(57.8)
Ceftazidime 9/29(31) 6/16(37.5)
Cefipime 11/52(21.2) 5/16(31.3)
Cefixime 2/58(3.5) 5/17(29.4)
Cefoperazone 1/23(4.4) NT
Quinolones
Levofloxacin 28/82(34.2) 32/45(71.1)
Ciprofloxacin 17/74(23) 49/92(53.3)
Norfloxacin 10/44(22.7) 26/55(47.3)
Ofloxacin 6/29(20.7) 6/11(54.5)
Nalidixic 7/40(17.5) NT
Penicillin
Oxacillin NT 8/8(100)
Piperacillin + tazobactam 71/111(71) 10/17(58.8)
Co-Amoxiclav 12/86(14) 13/25(52)
Penicillin NT 30/104(28.9)
Ampicillin 7/104(6.7) 12/46(26.1)
Carbapenems
Imipenem 81/101(80.2) 12/17(70.6)
Ertapenem 49/69(71) NT
Meropenem 81/108(75) 18/24(75)
Macrolide
Clarithromycin NT 16/19(84.2)
Erythromycin NT 89/133(66.9)
Aminoglycoside
Amikacin 87/103(84.5) 101/112(90.2)
Gentamicin 51/96(53.1) 85/108(78.7)
Tobramycin 30/59(50.9) 39/59(66.1)
Oxalidone
Linezolid NT 121/127(95.3)
Glycopeptide
Vancomycin NT 122/122(100)
Teicoplanin NT 46/66(69.7)
Lincomycin
Clindamycin NT 96/125(76.8)
Phosphonic acid Antibiotics
Fosfomycin 48/48(100) 3/3(100)
Polymyxin
Colistin 58/60(96.7) 11/11(100)
Polymyxin B 58/61(95.1) 11/12(91.7)
Antimycobacterials
Rifampicin NT 51/58(87.9)
Tetracycline
Tigecycline 52/56(92.9) 54/58(93.1)
Minocycline 20/44(45.5) 33/38(86.8)
Tetracycline 17/80(21.3) 43/80(53.7)
Sulfonamide
Nitrofurantoin 13/14(76.5) NT
Co-Trimoxazole 12/81(14.8) 21/83(25.3)
Others
Chloramphenicol 33/41(80.5) 71/77(92.2)

Abbreviation: NT, Not Tested.